LifeScience Emerging Biotech
BRIM appoints Andrew Lin as Chairman and Dr. Wen Chyi Shyu as CEO, secures $18M in Series E funding, and advances clinical trials for Dry Eye Disease and Neurotrophic Keratitis treatments
What led to the decision to elect Andrew Lin as the new Chairman of the Board, and how do you believe he will contribute to BRIM's continued succ...
March 01, 2023 | Opinion
Gene Solutions' Latest Update: Promising Multi-Cancer Early Detection in Southeast Asia
Circulating tumor DNA, or cell-free tumor DNA (ctDNA) assay is based on detecting the appearance of ctDNA in blood. This method is sometimes called Liquid ...
March 01, 2023 | News
Fapon Biopharma's Anti-CD47 Antibody FP002 Earns IND Approval from FDA
FP002 is a humanized anti-CD47 IgG4 monoclonal antibody, developed and patented by Fapon Biopharma. It binds strongly to the CD47 protein on the surface of...
February 23, 2023 | News
BRIM Biotechnology announces new leadership team
BRIM Biotechnology, Inc. (BRIM, TPEx 6885), a clinical-stage company developing novel regenerative therapies to help combat and cure ophthalmology and...
February 21, 2023 | News
Celltrion and LISCure Biosciences to develop novel microbiome treatment for Parkinson's disease
Co-research and co-development of novel microbiome therapeutics Discovery of new candidates to meet high unmet medical needs in Parkinson's disease U...
February 21, 2023 | News
RVAC Medicines Secures HSA Approval to Initiate Phase 1B Clinical Trial in Singapore
The clinical trial aims to evaluate three of RVAC's COVID-19 vaccine candidates that include one against the ancestral strain, one against an Omicron strai...
February 21, 2023 | News
"Fueling Growth and Innovation: The Rise of Biotech Investment in the Asia Pacific Region"
According to a report by Deloitte, the APAC biotech market is expected to grow at a compound annual growth rate (CAGR) of 10.9% between 2020 and 2025, with...
February 20, 2023 | News
Global Sarcoma Therapy Now Approved for New Zealand Patients
Globally regarded soft-tissue sarcoma therapy has been approved by Medsafe for New Zealand patients YONDELIS® (trabectedin) demonstra...
February 18, 2023 | News
Oxford Nanopore Technologies teams up with UPS Healthcare to accelerate delivery of next-generation DNA sequencing technology
Oxford Nanopore Technologies today announced an extension of its collaboration with UPS Healthcare to accelerate the delivery of Oxford Nanopore DNA/RNA se...
February 16, 2023 | News
Inventia Life Science collaborates with MSD to develop 3D advanced cell models
Collaboration to develop 3D in vitro models of the brain for the discovery of therapeutic candidates using Inventia's novel 3D cell culture platform, RASTR...
February 16, 2023 | News
Vir Biotechnology Announces Amended Collaboration Agreement with GSK
Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that the research collaboration agreement established with GSK in 2020 has been amended to reflect th...
February 14, 2023 | News
HanAll Biopharma Invests in Interon to Seek Collaboration Opportunities
HanAll will invest in Interon Laboratories, a preclinical-stage biotechnology company focused on treating complex neurological disorders Interon is deve...
February 13, 2023 | News
Halucenex Life Sciences Inc. targets Australian market following landmark TGA decision
Creso Pharma Limited (ASX:CPH, FRA:1X8) ('Creso Pharma') is pleased to announce its wholly-owned psychedelics subsidiary, Halucenex Life Sciences...
February 09, 2023 | News
Microba and BioAgilytix announce partnership to fast-track therapeutic delivery
Enables innovators to confidently leverage microbiome endpoints in clinical trials Delivers superior outcomes for clients at each stage of the d...
February 09, 2023 | News
Most Read
- Why Cell Therapy Systems Are Going Automatic: A New Era of Manufacturing
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Ravindra Rao Joins GOBI Technologies as Director of Life Sciences – APAC
- Amgen Announces $900 Million Expansion of Ohio Biomanufacturing Facility, Boosting Investment to Over $1.4 Billion
- Thermo Fisher Scientific Appoints Former CVS Health CEO Karen S. Lynch to Board of Directors
- Merck KGaA Reshapes Leadership for the Future with Key Executive Moves
- Aarian Health Appoints Thomas Keller as Business Director to Drive Innovation and Growth
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
News
